Cranial Implant Market – By Product, By Material, By Application, By End Use – Global Forecast, 2025 to 2034

Cranial Implant Market Size

The global cranial implant market was estimated at USD 1.6 billion in 2024. The market is expected to grow from USD 1.7 billion in 2025 to USD 2.9 billion by 2034 at a CAGR of 6.4% during the forecast period. A cranial implant is a type of medical device which is used to repair or replace a section of the skull due to trauma, congenital defects, tumors, or neurosurgical procedures. These implants are made of biocompatible materials such as titanium, polyetheretherketone (PEEK), or customized 3D-printed materials designed to match the patient’s cranial anatomy.
 

The global market is experiencing significant growth, driven by an increasing cases of traumatic brain injuries (TBI). For instance, according to the data from a research study, in 2021 there were 20.84 million incident cases and 37.93 million prevalent cases of traumatic brain injury (TBI) globally, which resulted in 5.48 million years lived with disability (YLDs). These rates were higher in males than females. Thus, this statistic highlights the growing need for advanced cranial implants which helps to support skull reconstruction, helps to improve patient outcomes, and also address the long-term impact of traumatic brain injuries.
 

Additionally, growing prevalence of neurological disorders, such as stroke, epilepsy, Parkinson’s disease, Alzheimer’s disease, multiple sclerosis (MS). Many of these conditions, which leads to skull deformities also require surgical intervention, which creates demand for cranial implants. For instance, according to the study published in The Lancet Neurology, in 2021 more than 3 billion individuals, globally lived with a neurological condition. Over 80% of neurological deaths and health loss occur in low-and middle-income countries. Further, neurological conditions are being the leading cause of ill health and disability globally. Thus, this alarming statistic highlights the need for cranial implants to support skull reconstruction, which improves patient outcomes.
 

 Cranial Implant Market Trends

• Technological advancements in 3d printing and innovation in custom implant are transforming cranial implant procedures, which enables for greater precision and patient-specific solutions. Initially, cranial implants were developed by using standard materials, but now 3D printing has significantly improved the way of customization, specifically for complex skull reconstructions.
   
• In addition to the advancement, such as patient-specific polyetheretherketone (PEEK) and titanium implants, have been manufactured to boost the biocompatibility, durability, and the integration with encompassing bone structures. These innovations, minimizes the surgical complications and also improves the post operative outcomes.
   
• For instance, in April 2024, 3D Systems received the FDA approval for its VSP PEEK cranial implant, the additively manufactured PEEK implant intended for cranioplasty procedures to restore skull defects. Thus, this technology facilitates patient-specific cranial implants using up to 85% less material than traditional machining, reducing costs for high-priced implantable PEEK.
   
• Further, combining 3D printing with imaging technologies such as CT scanner, which is estimated to reach USD 11.5 billion by 2032, and MRI, helps in accurate pre-surgical planning, which leads to better fit and functions of implants.
   
• For instance, as per a study published in National Institute of Health (NIH), it is possible to create patient-specific acrylic cranioplasty implants using a low-cost 3D printer. This fascinating method has the potential to offer personalized medication to more patients around the world.
   
• Moreover, substantial progress has been made in bioresorbable materials and regenerative implants, which are projected to escalate the market expansion. Advances in scaffolding techniques and bioprinting of bone-mimicking materials are developing skull defect reconstructions, which ensures better osteointegration and long-term stability.
   
• For example, 3D printing has enabled the development of cranial implants which are made from hydroxyapatite, a ceramic know as bone mineral, which actively promotes new bone growth and integration.
   
• Thus, these innovations in 3D printing and custom implants demonstrate the new era of cranial reconstruction, which optimizes surgical efficacy and patient outcomes. Ongoing research into smart implants inserted with sensors for real time monitoring is further escalating the scope of cranial implant technologies, which contributes to the market growth.
   

Cranial Implant Market Analysis

Based on product, the market is segmented into customized and non-customized. The market was estimated at USD 1.5 billion in 2023. The customized held revenue of USD 1 billion in 2024 and the segment is poised for significant growth at a CAGR of 6.5% during the forecast period.
 

• Customized cranial implants provide significant benefits in reconstructive surgery, mainly due to their enhanced fit and precision. By using advanced imaging technologies such as MRI and CT scanners, these implants are accurately developed to match the patients anatomical structure.
   
• For instance, Stryker provides PEEK customized implants which are individually crafted to replace specific bony voids in the cranial and craniofacial skeleton, providing a "drop-in" fit that enhances surgical outcomes.
   
• In addition, the use of patient specific implants has been associated with the improves aesthetic and functional outcomes. By restoring the natural contour of the skull, these implants minimizes the visible deformities, helps in enhancing patient confidence and psychological well-being. Thus, the research study highlighted that large skull reconstructions using customized cranial implants not only restore cerebral protection and physiological homeostasis but also substantially improve cosmetic results.
   
• Moreover, the accuracy and biocompatibility of customized cranial implants contribute to a lower risk of postoperative complications. Materials such as polyetheretherketone (PEEK) and titanium are frequently used due to their satisfactory properties, including strength and compatibility with human tissue.
   
• For example, LASAK's Cranio-Oss custom implants are made from synthetic biomaterials such as pure titanium or PEEK, provides precise geometry tailored to the patient's CT data, which improves biocompatibility and reduces the likelihood of implant rejection.
  
   

Based on material, the cranial implant market is bifurcated into metal, polymer, and ceramic. The metal segment accounted for a revenue share of 52.5% and with revenue of USD 830.9 million in 2024.
 

• Metal cranial implants, specifically those are made of titanium and titanium alloys, are recognized for their special strength and longevity. Unlike polymer-based implants, metal based offers robust structural support, which makes them ideal for protecting the brain after the traumatic injuries. Their ability to withstand mechanical stress makes them a long term solution with minimal risk of the implant failure.
   
• For instance, KLS Martin Group had launched a new range of patient-specific 3D-printed titanium cranial implants, which offers improved structural stability and long-term patient outcomes.
   
• In addition, metals notably titanium, are broadly used in cranial implants due to their high biocompatibility, which means that they do not cause adverse reactions. Titanium naturally forms a protective oxide layer, which makes it highly corrosion free, helps in preventing material degradation within the body
   
• Further, titanium’s ability to integrate naturally with bone tissue, is a process known as osseointegration. This feature enhances implant stability, helps in minimizing the probability of implant movement or loosening over time.
   

Based on application, the cranial implant market is bifurcated into traumatic brain injuries, tumor resection cases, neurosurgical reconstructive procedures, and other applications. The traumatic brain injuries segment accounted for a 42.2% market share in 2024.
 

• Cranial implants play a vital role in the treatment and rehabilitation of patients with traumatic brain injuries (TBI), specifically when skull damages has occurred. These implants are mainly used in cranioplasty, a surgical procedure which is aimed at repairing skull defects caused due severe trauma, decompressive craniectomy, or previous surgical interventions.
   
• The choice of implant material substantially influences patient outcomes. For instance, a study published in National institute of Health (NIH) states that polymethyl methacrylate (PMMA) has been associated with lower revision rates compared to autologous bone, signifying its therapeutic benefit for selected patients with traumatic cranial defects.
   
• Further, patients with severe TBI are at high risk of post-traumatic infections, cerebrospinal fluid leaks, and bone resorption. Custom cranial implants are made of biocompatible materials such as titanium and PEEK which helps to minimize these risks, while stimulating long-term recovery.
   

Based on end use, the cranial implant market is bifurcated into hospitals, neurosurgery centers, and academic and research institutes. The hospitals segment accounted for a 55.6% market share in 2024.
 

• Hospitals encounter a greater number of patients undergoing complex neurosurgical procedures which include cranioplasty, tumor resections, and implantation of cranial prosthetics.  
   
• Hospitals capability to address larger volume of neurosurgical patients in both emergency as well as in patient department making them a key contributor for the number of cranial implant procedures performed, thereby propelling the market growth.
   
• Moreover, hospital encompass large number of skilled professionals such as neurosurgeons and the supporting staff under the neurology department of the hospitals, making them a preferred choice among the patients undergoing both emergency and elective cranial implant procedures.
   
• Furthermore, these facilities are well equipped with high end neurosurgical implants and laboratories such as the imaging suits,3D printing units for custom implants, thereby boosting the segmental growth.
   

The North America cranial implant market is accounted for USD 640.6 million revenues in 2024 forecasted to reach USD 1.2 billion by 2034. The U.S. dominated the North America market with the largest revenue of USD 555.3 million in 2023.
 

• This growth is largely attributed to the increasing prevalence of traumatic brain injuries (TBI) in the U.S.
   
• For instance, in 2021, as per the data from the Centers for Disease Control and Prevention (CDC), there were approximately 214,110 TBI-related hospitalizations in 2020 and 69,473 TBI-related deaths in 2021. Thus, this represents more than 586 TBI-related hospitalizations and 190 TBI-related deaths per day.
   
• Additionally, despite a stringent regulatory environment, there is strong support for the approval and commercialization of innovative healthcare solutions such as cranial implant.
   
• Moreover, the technological advancements and adoption of the advanced cranial implant across the country are further boosting the growth of the market in the country.
   

Europe: The cranial implant market in UK is expected to experience significant and promising growth from 2025 to 2034.
 

• The country’s well established healthcare system and the rising demand for advanced neurosurgical procedures are the key factors stimulating the growth of the market in the country.
   
• Moreover, the growing aging population base and an increasing awareness regarding the advance neurosurgical procedures further solidifying the growth of market in the country.
   
• For instance, as per the data from Office for National Statistics, the elderly population of the UK is expected to rise significantly. In 2020, an estimated 2.5% of the total population comprised of people aged 85 and over, by 2040 the figure is projected to reach 4.3% of the total population.
   
• Thus, this demographic shift stimulates the need for high quality cranial implant in order to address the age-related neurological condition such as skull deformities, brain injuries, and tumors, thereby fostering the market growth in the region.
   

Asia Pacific: Japan cranial implant market is anticipated to witness lucrative growth between 2025 – 2034.
 

• The country has one of fastest aging population which necessities frequent neurologically health monitoring. Cranial implants provides an effective and convenient option for elderly care requiring due to trauma, tumors, or degenerative condition, impelling their adoption in the country.
   
• For example, in 2023 projections from the World Economic Forum revealed that 1 in 10 people in Japan are aged 80 years and above which is about one-third of the population.
   
• Thus, this demographic shift has created awareness among the healthcare providers and policy makers for the need of effective strategies to address neurological disorders and cranial reconstructive needs, thereby escalating the market growth.
   

Middle East and Africa: The cranial implant market in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.
 

• Saudi Arabia’s advance healthcare infrastructure and rising investment in advanced healthcare technologies create opening for the development and adoption of advanced cranial implant tailored to the country’s patient specific needs.
   
• Further, the rising awareness regarding the benefits of cranial implants for brain injury recovery and skull deformities across various age group of individuals in the country, further propelling the market growth.
   

Cranial Implant Market Share

The top 5 players of the market account for approximately 40% of the market share which includes companies such as 3D Systems, Johnson & Johnson, Medtronic, Stryker Corporation, Zimmer Biomet, among others. These companies maintain their dominance in the market through innovative product launches, extensive distribution networks and strong regulatory approval. Moreover, strategic partnerships with research institutes, and government agencies play a primary role in advancing the development of implants and getting the necessary permits. The development of public awareness about neurological conditions  and its health impact through the social media platform, will encourage more individuals to seek the treatment, enabling market players to strengthen their position in this growing sector.
 

Cranial Implant Market Companies

Some of the eminent market participants operating in the cranial implant industry include:

• 3D Systems
• Acumed LLC
• Anatomics Pty Ltd
• B. Braun SE
• Brainlab
• evonos GmbH & Co. KG
• Integra LifeSciences
• Johnson & Johnson
• Kelyniam Global Inc.
• KLS Martin
• Medartis AG
• Medtronic
• Matrix Surgical USA
• Renishaw plc.
• Stryker Corporation
• Zimmer Biomet
   
• Stryker Corporation has strong product portfolio leading to larger adoption and significant market expansion. Stryker provides a diverse range of products pertaining to cranial implants such as 3D systems, VSP cranial, among others.
   
• Medtronic has strong geographical presence which enables it to enhance its market reach. Medtronic operates in more than 150 countries thus comprising of a robust distribution network.
   
• Zimmer Biomet invests in research & development, fostering innovation and growth. The company continuously evolves with newest advancement in cranial implants.
   

Cranial Implant Industry News:

• In April 2024, 3D Systems announced that U.S. FDA had approved VSP PEEK cranial implant, 3D-printed, patient-specific cranial implant solution. This approval benefited the company by expanding its product portfolio in the market.
   
• In September 2022, Brainlab acquired Dr. langer Medical GmbH, a company that specialized in neuromonitoring solutions. Thus, this acquisition profited Brainlab by increasing its portfolio in the field of neurosurgery.
   

The cranial implant market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Customized
• Non-customized

Market, By Material

• Metal
• Polymer
  • Polyetheretherketone (PEEK)
  • Polymethylmethacrylate (PMMA)
  • Other polymers
• Ceramic

Market, By Application

• Traumatic brain injuries
• Tumor resection cases
• Neurosurgical reconstructive procedures
• Other applications 

Market, By End Use

• Hospitals
• Neurosurgery centers
• Academic and research institutes

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE